Stay updated on OPTIM Study: Immunotherapy in Head and Neck Clinical Trial

Sign up to get notified when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the optimization of immunotherapy in squamous carcinoma of the head and neck after prior platinum-based therapy. This change may be relevant to individuals monitoring medical and healthcare-related publications and documentation.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:32.000Z thumbnail image
  7. Check
    20 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    52%
    Check dated 2024-05-22T21:08:58.000Z thumbnail image
  8. Check
    42 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:23:45.000Z thumbnail image

Stay in the know with updates to OPTIM Study: Immunotherapy in Head and Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.